What development phase is Barbidorm in?

Barbidorm is FDA-approved (marketed).

What is the generic name of Barbidorm?

HEXOBARBITAL is the generic (nonproprietary) name of Barbidorm.

Last reviewed 2026-04-20 · How we verify

Barbidorm (HEXOBARBITAL)

FDA-approved withdrawn Small molecule Quality 19/100

At a glance

Generic name	HEXOBARBITAL
Drug class	hexobarbital
Target	GABA-A receptor alpha-1/beta-3/gamma-2, GABA-A receptor alpha-2/beta-3/gamma-2, GABA-A receptor alpha-3/beta-3/gamma-2
Modality	Small molecule
Therapeutic area	Neuroscience
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Barbidorm CI brief — competitive landscape report
Barbidorm updates RSS · CI watch RSS